While Yu et al. reported that HCC cells with decreased expression of DPP-4 had poorer survival outcomes, Nishina et al. found that the group with high expression of CD26 in mice showed more advanced tumor stages and lower overall survival [77,78]. The gene discussed is DPP4; the disease is hepatocellular carcinoma.